DFIN vs EXAS · P/E 20, rev $429.7M vs rev $2.76B
Donnelley Financial Solutions Inc (DFIN) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Donnelley Financial Solutions Inc (DFIN) is a software - application company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported DFIN revenue for 2026-06-30 was $429.7M. Net income was $69.9M. DFIN currently screens at market cap $1.69B and trailing P/E 20.2.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
DFIN currently screens at market cap $1.69B and trailing P/E 20.2. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the DFIN and EXAS stock pages for the full models.
Not investment advice.